Oral administration of doxycycline reduces collagenase and gelatinase activities in extracts of human osteoarthritic cartilage

Journal of Rheumatology

Volumn 25, Issue 3, 1998, Pages 532-535

  Smith Jr , Gerald N ^a,b,d   Yu Jr , Lucino P ^a,b   Brandt, Kenneth D ^a,c   Capello, William N ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Department of Medicine and Anatomy ^*

^c Rheumatology Division

^d INDIANA UNIVERSITY   (United States)

Author keywords

Collagenase; Doxycycline; Gelatinase; Osteoarthritis

Indexed keywords

COLLAGENASE; DOXYCYCLINE; GELATINASE;

ADULT; ARTHROPLASTY; ARTICLE; CLINICAL ARTICLE; DOSE RESPONSE; DRUG TOLERANCE; ENZYME ACTIVITY; GANGLIONECTOMY; HUMAN; ORAL DRUG ADMINISTRATION; OSTEOARTHRITIS; PRIORITY JOURNAL;

ADMINISTRATION, ORAL; ANTI-BACTERIAL AGENTS; CARTILAGE; COLLAGENASES; DOXYCYCLINE; GELATINASES; HUMANS; OSTEOARTHRITIS, HIP;

EID: 2642649541     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Yu LP Jr, Smith GN Jr, Brandt KD, Myers SL, O'Connor BL, Brandt DA. Reduction of the severity of canine osteoarthritis by prophylactic treatment with oral doxycycline. Arthritis Rheum 1992;35:1150-9.
2. Yu LP Jr, Smith GN Jr, Brandt KD, O'Connor BL, Myers SL. Therapeutic administration of doxycycline slows the progression of cartilage destruction in canine osteoarthritis [abstract]. Trans Orthop Res Soc 1993;18:724.
3. Greenwald RA. Treatment of destructive arthritis disorders with MMP inhibitors. Ann NY Acad Sci 1994;732:181-98.
4. Golub LM, Greenwald RA, Ramamurthy NS, McNamara TF, Rifkin BR. Tetracyclines inhibit connective tissue breakdown: new therapeutic implications for an old family of drugs. CRC Crit Rev Oral Biol Med 1991;2:297-321.
5. Smith GN Jr, Brandt KD, Hasty KA. Activation of recombinant human neutrophil procollagenase (MMP-8) in the presence of doxycycline results in fragmentation of the enzyme and loss of enzyme activity. Arthritis Rheum 1996;39:235-44.
6. Dean DD, Curry TE, LeMaire WJ, Woessner JF Jr. Determination of metalloproteinase activity after selective destruction of tissue inhibitor of metalloproteinases [abstract]. Trans Orthop Res Soc 1987;12:248.
7. 3H]acetylated collagen. Anal Biochem 1985;148:174-81.
8. Harris ED, Krane SM. An endopeptidase from rheumatoid synovial tissue culture. Biochem Biophys Acta 1972;258:566-76.
9. Xie D, Homandberg GA. Fibronectin fragments bind to and penetrate cartilage tissue resulting in proteinase expression and cartilage damage. Biochim Biophys Acta 1993;1182:189-96.
10. Brandt KD, Mankin HJ. Pathogenesis of osteoarthritis. In: Kelley WN, Harris ED Jr, Ruddy S, Sledge CB, editors. Textbook of rheumatology, 4th edition. Philadelphia: WB Saunders, 1993;1355-73.
11. Sandy JD, Flannery CR, Neame PJ, Lohmander LS. The structure of aggrecan fragments in human synovial fluid. Evidence for the involvement in osteoarthritis of a novel proteinase which cleaves the glu 373-ala 374 bond of the interglobular domain. J Clin Invest 1992;89:1512-6.
12. Flannery CR, Sandy JD. Identification of MMP-13 (collagenase-3) as the major matrix metalloproteinase expressed by chondrocytes during retinoic acid-induced matrix catabolism [abstract]. Trans Orth Res Soc 1995;20:102.
13. Mitchell PG, Magna HA, Reeves LM, et al. Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage. J Clin Invest 1996;97:761-8.
14. Greenwald RA, Golub LM, Lavietes B, et al. Tetracyclines inhibit human synovial collagenase in vivo and in vitro. J Rheumatol 1987;14:28-32.
15. Tilley B, Alarcon G, Heyse S, et al. Minocycline in rheumatoid arthritis. A 48-week double-blind, placebo-controlled trial. MIRA trial group. Ann Intern Med 1995;122:81-9.